<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(2)</volume><submitter>Van den Langenbergh J</submitter><funding>Gigtforeningen</funding><pubmed_abstract>&lt;h4>Objective&lt;/h4>To investigate associations between obesity-linked systemic factors and gene expression indicative for the inflammatory and fibrotic processes in the infrapatellar fat pad (IFP), in a population of obese patients with end-stage knee osteoarthritis (KOA).&lt;h4>Methods&lt;/h4>We collected human IFPs from 48 patients with a mean body mass index (BMI) of 35.44 ​kg/m&lt;sup>2&lt;/sup> during total knee replacement procedures. These patients were part of a randomized controlled trial and met the criteria of having OA and a BMI of ≥30 ​kg/m&lt;sup>2&lt;/sup>. Blood samples were collected to assess serum levels of glucose, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, and leptin. Total body composition was measured using dual-energy X-ray absorptiometry. Gene expressions of &lt;i>IL6, TNFA, COL1A1, IL1B, ASMA, PLOD2&lt;/i> in the IFP were analyzed.&lt;h4>Results&lt;/h4>Univariate analysis resulted in a positive correlation between BMI and procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (&lt;i>PLOD2&lt;/i>) expression (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.13). In univariate analyses of obesity-linked systemic factors and &lt;i>PLOD2&lt;/i>, significant correlations were found for lean mass (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.20), fat mass (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.20), serum cholesterol (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.17), serum triglycerides (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.19) and serum leptin (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.10). A multiple linear regression model indicated fat mass to be a strong predictor of PLOD2 production in the IFP (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.22, &lt;i>P&lt;/i> ​= ​0.003).&lt;h4>Conclusion&lt;/h4>Our study demonstrates the positive association between fat mass and &lt;i>PLOD2&lt;/i> expression in the IFP of obese end-stage knee OA patients. This may indicate that within this patient population the fibrotic process in the IFP is influenced by systemic adipose tissue, next to local inflammatory processes.</pubmed_abstract><journal>Osteoarthritis and cartilage open</journal><pagination>100469</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11061337</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>&lt;i>PLOD2&lt;/i> gene expression in infrapatellar fat pad is correlated with fat mass in obese patients with end-stage knee osteoarthritis.</pubmed_title><pmcid>PMC11061337</pmcid><pubmed_authors>Runhaar J</pubmed_authors><pubmed_authors>Mechlenburg I</pubmed_authors><pubmed_authors>Liljensoe A</pubmed_authors><pubmed_authors>Bierma-Zeinstra SMA</pubmed_authors><pubmed_authors>van Osch GJVM</pubmed_authors><pubmed_authors>Van den Langenbergh J</pubmed_authors><pubmed_authors>Kops N</pubmed_authors><pubmed_authors>Soballe K</pubmed_authors><pubmed_authors>Bastiaansen-Jenniskens YM</pubmed_authors><pubmed_authors>Clockaerts S</pubmed_authors><pubmed_authors>Laursen J</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>PLOD2&lt;/i> gene expression in infrapatellar fat pad is correlated with fat mass in obese patients with end-stage knee osteoarthritis.</name><description>&lt;h4>Objective&lt;/h4>To investigate associations between obesity-linked systemic factors and gene expression indicative for the inflammatory and fibrotic processes in the infrapatellar fat pad (IFP), in a population of obese patients with end-stage knee osteoarthritis (KOA).&lt;h4>Methods&lt;/h4>We collected human IFPs from 48 patients with a mean body mass index (BMI) of 35.44 ​kg/m&lt;sup>2&lt;/sup> during total knee replacement procedures. These patients were part of a randomized controlled trial and met the criteria of having OA and a BMI of ≥30 ​kg/m&lt;sup>2&lt;/sup>. Blood samples were collected to assess serum levels of glucose, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, and leptin. Total body composition was measured using dual-energy X-ray absorptiometry. Gene expressions of &lt;i>IL6, TNFA, COL1A1, IL1B, ASMA, PLOD2&lt;/i> in the IFP were analyzed.&lt;h4>Results&lt;/h4>Univariate analysis resulted in a positive correlation between BMI and procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (&lt;i>PLOD2&lt;/i>) expression (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.13). In univariate analyses of obesity-linked systemic factors and &lt;i>PLOD2&lt;/i>, significant correlations were found for lean mass (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.20), fat mass (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.20), serum cholesterol (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.17), serum triglycerides (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.19) and serum leptin (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.10). A multiple linear regression model indicated fat mass to be a strong predictor of PLOD2 production in the IFP (&lt;i>r&lt;/i>&lt;sup>2&lt;/sup> ​= ​0.22, &lt;i>P&lt;/i> ​= ​0.003).&lt;h4>Conclusion&lt;/h4>Our study demonstrates the positive association between fat mass and &lt;i>PLOD2&lt;/i> expression in the IFP of obese end-stage knee OA patients. This may indicate that within this patient population the fibrotic process in the IFP is influenced by systemic adipose tissue, next to local inflammatory processes.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-05-29T12:07:11.401Z</modification><creation>2026-04-08T04:41:37.944Z</creation></dates><accession>S-EPMC11061337</accession><cross_references><pubmed>38694906</pubmed><doi>10.1016/j.ocarto.2024.100469</doi></cross_references></HashMap>